Poly Medicure POLYMED
India's leading maker of medical disposables (IV cannulae, infusion and dialysis sets, catheters) moving into higher-value cardiology, renal and critical-care devices
Mapped in 1 theme: Hospitals & Healthcare.
Where Poly Medicure sits in the supply chain
Poly Medicure appears in 2 supply-chain layers in one theme, Hospitals & Healthcare.
Hospitals & Healthcare › Medical equipment & implants
Direct supplierOther companies in this layer
Hospitals & Healthcare › Disposables & hospital supplies
Direct supplierOther companies in this layer
Revenue and profit
| ₹ Cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | 922 | 1,115 | 1,375 | 1,669 | 1,875 |
| Net profit | 147 | 179 | 258 | 339 | 321 |
Latest-year revenue ₹1,875 Cr (FY26, company-wide).
Strengths
- Exports to over 100 countries with regulated-market approvals
- Consumables demand rises with every admission, not with capex cycles
- QIP-funded capacity and new product lines
Risks
- Commodity disposables face Chinese competition
- Currency and freight on exports
- New device categories take years of approvals
Common questions
What does Poly Medicure do?
India's leading maker of medical disposables (IV cannulae, infusion and dialysis sets, catheters) moving into higher-value cardiology, renal and critical-care devices.
Where does Poly Medicure sit in the supply chain?
Poly Medicure (NSE: POLYMED) is mapped in 2 supply-chain layers: Medical equipment & implants (Hospitals & Healthcare) and Disposables & hospital supplies (Hospitals & Healthcare).
Who are Poly Medicure's peers?
In the Disposables & hospital supplies layer of Hospitals & Healthcare: Tarsons Products, Linde India, Hindustan Syringes & Medical Devices (HMD) (not NSE-listed) and Healthium Medtech (not NSE-listed).
What is Poly Medicure's market cap and valuation?
As of 6 Nov 2026: market cap ₹16,380 Cr, P/E 51.8x, ROCE 12.5%, ROE 9.8%, dividend yield 0.22%.